InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Cobuzzi Robert Joseph Jr., Chairman & CEO. Director active across 1 companies, notably Diffusion Pharmaceuticals Inc.. In total, 8 reports have been logged. The latest transaction was filed on 18 April 2022 (C). Regulator: SEC (Form 4). The full history is free.
Declarations8 total
327 shares
Common Stock
SEC:0001437749-22-010718:0·
€2,319100 shares@ €23.1872100.0% of flow
Common Stock
SEC:0001437749-22-009234:0·
16,350 shares
Common Stock
SEC:0001437749-22-002262:0·
16,350 shares
Common Stock
SEC:0001437749-22-002262·
16,350 shares
Common Stock
SEC:0001437749-22-002263·
16,350 shares
Common Stock
SEC:0001437749-22-002263:0·
16,350 shares
Common Stock
SEC:0001437749-21-025138·
16,350 shares
Common Stock
SEC:0001437749-21-025138:0·
8 of 8 declarations
About Cobuzzi Robert Joseph Jr.
Robert Joseph Cobuzzi Jr. is the Chairman and CEO of Diffusion Pharmaceuticals Inc. He is responsible for the strategic direction of the company, which specializes in developing innovative treatments for critical medical conditions. His leadership aims to advance the company's mission and improve outcomes for patients.
